An article on the Arthritis Care website posted on the 8th October 2009 looks at the progress and potential of a new drug for Rheumatoid Arthritis.
Launched in the UK by its manufacturers on 8 October 2009. Tocilizumab, (brand name RoActemra) is intended for people with moderate to severe rheumatoid arthritis (RA) for whom existing treatments do not work. Read more… »